DEVOL

BMI OrganBank Receives 2026 Luis Villalobos Award

August 25, 2026

Angel Capital Association recognizes innovation in organ preservation and transplantation. BMI OrganBank is proud to announce that it has received the 2026 Luis Villalobos Award for Innovation in Life Sciences, presented by…

Head-to-Head Preclinical Data Demonstrates Reduced Delayed Graft Function with OrganBank Kidney

February 10, 2026

Compared to hypothermic machine preservation, OrganBank Kidney showed more consistent early graft performance in a controlled preclinical transplant model BMI OrganBank recently presented new preclinical data at the American Society of…

BMI OrganBank Secures FDA Breakthrough Device Designation for Innovative Kidney Transplant Technology

August 4, 2025

BMI OrganBank is developing novel medical devices with potential to significantly reduce the waitlist for lifesaving organ transplants, beginning with kidneys FDA Breakthrough Device Designation secures additional FDA engagement in…

BMI OrganBank, Atrium Health and LifeShare Carolinas Partner to Launch Nation’s First Organ Banking Technology

February 22, 2024

BMI OrganBank™ is developing novel organ perfusion systems with potential to greatly reduce the waitlist for lifesaving organ transplants. Partnership includes early access to BMI technologies, collaboration on product design,…

BMI OrganBank™ Selected by the North Carolina Biotechnology Center for Funding to Advance Medical Device

October 25, 2023

BMI OrganBank is developing novel organ perfusion systems with potential to greatly reduce the waitlist for lifesaving organ transplants. Funding will advance commercial readiness of OrganBank Transport medical device and…

BioMedInnovations Research Published in Frontiers in Medicine

February 24, 2022

BioMedInnovations reports the publication of a new article in the prestigious journal Frontiers in Medicine – “Two Compartment Evaluation of Liver Grafts During Acellular Room Temperature Machine Perfusion (acRTMP) in…

BioMedInnovations Announces Exclusive License Agreement with Duke University for Acellular Perfusate/Preservative Solution for Organs and Tissues

February 2, 2022

BioMedInnovations (BMI) announces an exclusive license agreement with Duke University, Durham, NC, to commercialize and bring a new acellular solution for the perfusion and preservation of organs and tissue in…

BioMedInnovations Announces Porcine Kidney Autotransplantation Study

February 2, 2022

Following extensive preclinical testing of the OrganBank™ device for kidney preservation, BioMedInnovations announced the next phase of its research program: an autotransplantation study involving the explantation, ex-vivo perfusion, and re-implantation…

BioMedInnovations Completes Extensive Preclinical Testing of OrganBank™

January 15, 2022

BioMedInnovations announced the completion of an extensive preclinical testing program evaluating its OrganBank™ organ perfusion device for the preservation and perfusion of kidneys. Conducted over a 26-month period, the program…

Blood-free perfusate

Real-time visibility across the journey

Portable perfusion. Continuous preservation.